No Data
No Data
B. Riley Initiates Anika Therapeutics at Buy With $21 Price Target
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Anika Therapeutics Announces COO Departure and Role Elimination
Express News | Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says